These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 6198518)
1. Synthesis of 2-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5-yl) benzo heterocycles. A novel series of orally active antiallergic agents. Musser JH; Brown RE; Loev B; Bailey K; Jones H; Kahen R; Huang FC; Khandwala A; Leibowitz M; Sonnino-Goldman P J Med Chem; 1984 Feb; 27(2):121-5. PubMed ID: 6198518 [TBL] [Abstract][Full Text] [Related]
2. 1,2,4-Triazolo[4,3-a]quinoxaline-1,4-diones as antiallergic agents. Loev B; Musser JH; Brown RE; Jones H; Kahen R; Huang FC; Khandwala A; Sonnino-Goldman P; Leibowitz MJ J Med Chem; 1985 Mar; 28(3):363-6. PubMed ID: 2579236 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines. Musser JH; Jones H; Sciortino S; Bailey K; Coutts SM; Khandwala A; Sonnino-Goldman P; Leibowitz M; Wolf P; Neiss ES J Med Chem; 1985 Sep; 28(9):1255-9. PubMed ID: 2411926 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414. Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252 [TBL] [Abstract][Full Text] [Related]
5. Pyrido[3',2':4,5]thieno[3,2-d]-N-triazines: a new series of orally active antiallergic agents. Youssefyeh RD; Brown RE; Wilson J; Shah U; Jones H; Loev B; Khandwala A; Leibowitz MJ; Sonnino-Goldman P J Med Chem; 1984 Dec; 27(12):1639-43. PubMed ID: 6150114 [TBL] [Abstract][Full Text] [Related]
6. Antiallergic activity profile in vitro of RHC 2963 and related compounds. Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Youssefyeh RD Int J Immunopharmacol; 1983; 5(6):491-502. PubMed ID: 6198298 [TBL] [Abstract][Full Text] [Related]
7. [1,4]Benzoxazine-2,3-diones as antiallergic agents. Loev B; Jones H; Brown RE; Huang FC; Khandwala A; Leibowitz MJ; Sonnino-Goldman P J Med Chem; 1985 Jan; 28(1):24-7. PubMed ID: 2578192 [TBL] [Abstract][Full Text] [Related]
8. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. I. A lack of correlation between inhibition of cyclic nucleotide phosphodiesterases and antigen-induced release of histamine from rat mast cells. Khandwala A; Van Inwegen R; Coutts S; Dally-Meade V; Jariwala N; Huang F; Musser J; Brown R; Loev B; Weinryb I Int Arch Allergy Appl Immunol; 1984; 73(1):56-64. PubMed ID: 6198287 [TBL] [Abstract][Full Text] [Related]
9. RHC 3288 [1-methyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl) benzimidazole] and related compounds. Novel inhibitors of histamine release from rat mast cells and human basophils. Khandwala A; Coutts S; Dally-Meade V; Jariwala N; Musser J; Brown R; Jones H; Loev B; Weinryb I Biochem Pharmacol; 1983 Nov; 32(22):3325-33. PubMed ID: 6197075 [TBL] [Abstract][Full Text] [Related]
10. Nitrogen bridgehead compounds. 18. New antiallergic 4H-pyrido[1,2-a]pyrimidin-4-ones. 1. Hermecz I; Breining T; Mészáros Z; Horváth A; Vasvári-Debreczy L; Dessy F; DeVos C; Rodriguez L J Med Chem; 1982 Oct; 25(10):1140-5. PubMed ID: 6183427 [TBL] [Abstract][Full Text] [Related]
11. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release. Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo activity profile of RHC 2851: a new orally effective antiallergic agent. Khandwala A; Carlson R; Dally-Meade V; Donigi-Ruzza D J Immunopharmacol; 1983; 5(4):311-32. PubMed ID: 6199431 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiallergic activity of N-[4-(4-diphenylmethyl-1-piperazinyl)butyl]-1,4-dihydro-4-oxopyridine-3 - carboxamides. Nishikawa Y; Shindo T; Ishii K; Nakamura H; Kon T; Uno H; Matsumoto J Chem Pharm Bull (Tokyo); 1989 May; 37(5):1256-9. PubMed ID: 2483534 [TBL] [Abstract][Full Text] [Related]
14. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models. Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860 [TBL] [Abstract][Full Text] [Related]
15. Benzopyrones. 14. Synthesis and antiallergic properties of some N-tetrazolylcarboxamides and related compounds. Ellis GP; Becket GJ; Shaw D; Wilson HK; Vardey CJ; Skidmore IF J Med Chem; 1978 Nov; 21(11):1120-6. PubMed ID: 82617 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of 3,4-dihydro-4-oxothieno[2,3-d]pyrimidine-2-carboxylates, a new series of orally active antiallergy agents. Temple DL; Yevich JP; Covington RR; Hanning CA; Seidehamel RJ; Mackey HK; Bartek MJ J Med Chem; 1979 May; 22(5):505-10. PubMed ID: 88521 [TBL] [Abstract][Full Text] [Related]
17. Antiallergic effects of 4-[2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy]-bu tyric acid. Kuriyama K; Hiyama Y; Ito K Jpn J Pharmacol; 1989 Jun; 50(2):111-8. PubMed ID: 2475659 [TBL] [Abstract][Full Text] [Related]
18. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate. Nabe T; Yamamura H; Kohno S; Ohata K Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084 [TBL] [Abstract][Full Text] [Related]
20. Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats. De Vos C; Dessy F; Hermecz I; Meszaros Z; Breining T Int Arch Allergy Appl Immunol; 1982; 67(4):362-8. PubMed ID: 6175586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]